Cite
Metabolic abnormalities associated with initiation of systemic treatment for psoriasis: evidence from the Italian Psocare Registry
MLA
Bongiorno, Maria Rita, et al. Metabolic Abnormalities Associated with Initiation of Systemic Treatment for Psoriasis: Evidence from the Italian Psocare Registry. Jan. 2013. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......3658..ce6c7a1396b33753f210cf2520ee556f&authtype=sso&custid=ns315887.
APA
Bongiorno, M. R., Gisondi, P., Cazzaniga, S., Chimenti, A., Giannetti, M., Maccarone, M., Picardo, G., Girolomoni, L., & Naldi, L. (2013). Metabolic abnormalities associated with initiation of systemic treatment for psoriasis: evidence from the Italian Psocare Registry.
Chicago
Bongiorno, Maria Rita, P Gisondi, S Cazzaniga, A Chimenti, M Giannetti, M Maccarone, G Picardo, L Girolomoni, and L. Naldi. 2013. “Metabolic Abnormalities Associated with Initiation of Systemic Treatment for Psoriasis: Evidence from the Italian Psocare Registry,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......3658..ce6c7a1396b33753f210cf2520ee556f&authtype=sso&custid=ns315887.